Abstract
The high-performance liquid chromatographic (HPLC) analysis of dipazinol, an anti-Parkinsonian drug, using either ultraviolet (UV) absorbance detection at 282 nm or oxidative amperometric electrochemical detection at the glassy carbon electrode (+0.92 V vs. Ag/AgCl) is described and evaluated. The influence of such factors as mobile phase composition, pH and column temperature on the detection of dopazinol using both detectors is reported. The HPLC analysis of samples resulting from the development and evaluation of a pharmaceutical formulation demonstrated a precision of <2.5% (R.S.D.) in the working ranges of the UV and electrochemical detectors. The limits of detection were 100 ng/ml for the UV detector and 1 ng/ml for the electrochemical detector. The higher sensitivity of the latter makes its use appropriate for the analysis of samples with low concentrations of dopazinol. Studies to compare the UV and electrochemical detectors for the routine analysis of dopazinol in pharmaceutical formulations are presented.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
